Usefulness of Follow-Up Low-Density Lipoprotein Cholesterol Level as an Independent Predictor of Changes of Coronary Atherosclerotic Plaque Size as Determined by Intravascular Ultrasound Analysis After Statin (Atorvastatin or Simvastatin) Therapy

American Journal of Cardiology

Volumn 98, Issue 7, 2006, Pages 866-870

  Hong, Myeong Ki ^a   Lee, Cheol Whan ^a   Kim, Young Hak ^a   Park, Duk Woo ^a   Lee, Se Whan ^a   Park, Chang Bum ^a   Jang, Jae Sik ^a   Han, Ki Hoon ^a   Cheong, Sang Sig ^b   Kim, Jae Joong ^a   Park, Seong Wook ^a   Park, Seung Jung ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b GangNeung   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTRAVASCULAR ULTRASOUND; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

CHOLESTEROL; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DATABASES; ELASTIC TISSUE; FEMALE; FOLLOW-UP STUDIES; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PYRROLES; SIMVASTATIN; TUNICA MEDIA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33748786789     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.04.025     Document Type: Article

References (15)

1. Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebo controlled trial. Lancet 360 (2002) 7-22
2. Schwartz G.G., Olsson A.G., Ezekowitz M.D., Ganz P., Oliver M.F., Waters D., Zeiher A., Chaitman B.R., Leslie S., Stern T., and Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285 (2001) 1711-1718
3. Cannon C.P., Braunwald E., McCabe C.H., Rader D.J., Rouleau J.L., Belder R., Joyal S.V., Hill K.A., Pfeffer M.A., Skene A.M., and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 (2004) 1495-1504
4. Bonetti P.O., Lerman L.O., Napoli C., and A L. Statin effects beyond lipid lowering-are they clinically relevant?. Eur Heart J 24 (2003) 225-248
5. Jukema J.W., Bruschke A.V., van Boven A.J., Reiber J.H.C., Bal E.T., Zwinderman A.H., Jansen H., Boerma G.J.M., van Rappard F.M., and Lie K.I. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 91 (1995) 2528-2540
6. MAAS Investigators. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS). Lancet 344 (1994) 633-638
7. Okazaki S., Yokoyama T., Miyauchi K., Shimada K., Kurata T., Sato H., and Daida H. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study. Circulation 110 (2004) 1061-1068
8. Jensen L.D., Thayssen P., Pedersen K.E., Stender S., and Haghfelt T. Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Circulation 110 (2004) 265-270
9. Nissen S.E., Tuzcu E.M., Schoenhagen P., Brown B.G., Ganz P., Vogel R.A., Crowe T., Howard G., Cooper C.J., Brodie B., et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291 (2004) 1071-1080
10. Mintz G.S., Nissen S.E., Anderson W.D., Bailey S.R., Erbel R., Fitzgerald P.J., Pinto F.J., Rosenfield K., Siegel R.J., Tuzcu E.M., and Yock P.G. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS): a report of the American College of Cardiology task force on clinical expert consensus documents. J Am Coll Cardiol 37 (2001) 1478-1492
11. Takagi T., Yoshida K., Akasaka T., Hozumi T., Morioka S., and Yoshikawa J. Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin. Am J Cardiol 79 (1997) 1673-1676
12. Schartl M., Bocksch W., Koschyk D.H., Voelker W., Karsch K.R., Kreuzer J., Hausmann D., Beckmann S., and Gross M. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 104 (2001) 387-392
13. von Birgelen C., Martmann M., Mintz G.S., Baumgart D., Schmermund A., and Erbel R. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (≥12 months) follow-up intravascular ultrasound. Circulation 108 (2003) 2757-2762
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 285 (2001) 2486-2497
15. Wood D., De Backer G., Faergeman O., Graham I., Mancia G., Pyörälä K., and with members of the Task Force. Prevention of coronary heart disease in clinical practice: recommendations of the second joint task force of European and other societies on coronary prevention. Atherosclerosis 140 (1998) 199-270